These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36804913)

  • 1. Rewriting the message: Harnessing RNA pseudouridylation to tackle disease.
    Montes M; Martínez NM
    Mol Cell; 2023 Feb; 83(4):503-506. PubMed ID: 36804913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons.
    Song J; Dong L; Sun H; Luo N; Huang Q; Li K; Shen X; Jiang Z; Lv Z; Peng L; Zhang M; Wang K; Liu K; Hong J; Yi C
    Mol Cell; 2023 Jan; 83(1):139-155.e9. PubMed ID: 36521489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting nonsense codons into sense codons by targeted pseudouridylation.
    Karijolich J; Yu YT
    Nature; 2011 Jun; 474(7351):395-8. PubMed ID: 21677757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutics based on stop codon readthrough.
    Keeling KM; Xue X; Gunn G; Bedwell DM
    Annu Rev Genomics Hum Genet; 2014; 15():371-94. PubMed ID: 24773318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing nonsense suppression by targeted pseudouridylation.
    Huang C; Wu G; Yu YT
    Nat Protoc; 2012 Mar; 7(4):789-800. PubMed ID: 22461068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine CGA codons as a source of nonsense mutations: a possible role in multivariant gene expression, control of mRNA quality, and aging.
    Romanov GA; Sukhoverov VS
    Mol Genet Genomics; 2017 Oct; 292(5):1013-1026. PubMed ID: 28523359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus.
    Weil JE; Beemon KL
    RNA; 2006 Jan; 12(1):102-10. PubMed ID: 16301601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum starvation enhances nonsense mutation readthrough.
    Wittenstein A; Caspi M; David Y; Shorer Y; Nadar-Ponniah PT; Rosin-Arbesfeld R
    J Mol Med (Berl); 2019 Dec; 97(12):1695-1710. PubMed ID: 31786671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic Disorders.
    Asiful Islam M; Alam F; Kamal MA; Gan SH; Wong KK; Sasongko TH
    Curr Pharm Des; 2017; 23(11):1598-1609. PubMed ID: 27875971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.
    Caspi M; Firsow A; Rajkumar R; Skalka N; Moshkovitz I; Munitz A; Pasmanik-Chor M; Greif H; Megido D; Kariv R; Rosenberg DW; Rosin-Arbesfeld R
    J Mol Med (Berl); 2016 Apr; 94(4):469-82. PubMed ID: 26620677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors.
    Lee C; Hyun Jo D; Hwang GH; Yu J; Kim JH; Park SE; Kim JS; Kim JH; Bae S
    Mol Ther; 2019 Aug; 27(8):1364-1371. PubMed ID: 31164261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context analysis of termination codons in mRNA that are recognized by plant NMD.
    Hori K; Watanabe Y
    Plant Cell Physiol; 2007 Jul; 48(7):1072-8. PubMed ID: 17567637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMD: RNA biology meets human genetic medicine.
    Bhuvanagiri M; Schlitter AM; Hentze MW; Kulozik AE
    Biochem J; 2010 Sep; 430(3):365-77. PubMed ID: 20795950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae.
    Altamura E; Borgatti M; Finotti A; Gasparello J; Gambari R; Spinelli M; Castaldo R; Altamura N
    PLoS One; 2016; 11(4):e0154260. PubMed ID: 27119736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of nonsense mRNA: towards a unified model.
    Mühlemann O
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):497-501. PubMed ID: 18481988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered transfer RNAs for suppression of premature termination codons.
    Lueck JD; Yoon JS; Perales-Puchalt A; Mackey AL; Infield DT; Behlke MA; Pope MR; Weiner DB; Skach WR; McCray PB; Ahern CA
    Nat Commun; 2019 Feb; 10(1):822. PubMed ID: 30778053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic suppression of premature termination codons: mechanisms and clinical considerations (review).
    Karijolich J; Yu YT
    Int J Mol Med; 2014 Aug; 34(2):355-62. PubMed ID: 24939317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binary specification of nonsense codons by splicing and cytoplasmic translation.
    Thermann R; Neu-Yilik G; Deters A; Frede U; Wehr K; Hagemeier C; Hentze MW; Kulozik AE
    EMBO J; 1998 Jun; 17(12):3484-94. PubMed ID: 9628884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.
    Dabrowski M; Bukowy-Bieryllo Z; Zietkiewicz E
    Mol Med; 2018 May; 24(1):25. PubMed ID: 30134808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic promise of engineered nonsense suppressor tRNAs.
    Porter JJ; Heil CS; Lueck JD
    Wiley Interdiscip Rev RNA; 2021 Jul; 12(4):e1641. PubMed ID: 33567469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.